Citation | Xue, CB; Feng, H; Cao, G; Huang, T; Glenn, J; Anand, R; Meloni, D; Zhang, K; Kong, L; Wang, A; Zhang, Y; Zheng, C; Xia, M; Chen, L; Tanaka, H; Han, Q; Robinson, DJ; Modi, D; Storace, L; Shao, L; Sharief, V; Li, M; Galya, LG; Covington, M; Scherle, P; Diamond, S; Emm, T; Yeleswaram, S; Contel, N; Vaddi, K; Newton, R; Hollis, G; Friedman, S; Metcalf, B Discovery of INCB3284, a Potent, Selective, and Orally Bioavailable hCCR2 Antagonist. ACS Med Chem Lett2:450-454 (2011) [PubMed] Article |
---|
SMILES | O[C@]1(CC[C@@H](CC1)N1CC[C@H](C1)NC(=O)CNC(=O)c1cccc(c1)C(F)(F)F)c1cnccn1 |r,wU:4.7,wD:10.13,1.0,(-5.05,-16.35,;-4.27,-17.69,;-3.46,-19.01,;-1.93,-18.98,;-1.18,-17.63,;-1.98,-16.31,;-3.53,-16.34,;.36,-17.6,;1.28,-18.82,;2.73,-18.32,;2.7,-16.78,;1.23,-16.33,;4.03,-15.99,;5.37,-16.75,;5.39,-18.29,;6.7,-15.96,;8.04,-16.71,;9.36,-15.93,;9.34,-14.39,;10.71,-16.68,;10.72,-18.22,;12.06,-18.97,;13.38,-18.18,;13.36,-16.64,;12.02,-15.89,;14.68,-15.85,;16.03,-16.59,;14.66,-14.31,;16.01,-15.07,;-5.81,-17.73,;-6.61,-16.41,;-8.15,-16.45,;-8.89,-17.8,;-8.1,-19.12,;-6.55,-19.09,)| |